{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:52:34Z","timestamp":1769633554377,"version":"3.49.0"},"reference-count":48,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":3913,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2001,5]]},"abstract":"<jats:p>Sedation is an important aspect of care for critically ill newborns. Proper sedation reduces stress during procedures such as mechanical ventilation. Midazolam, a short\u2010acting benzodiazepine, is widely administered as a sedative in newborn intensive care units but is not without side effects. Three term newborns developed myoclonic\u2010like abnormal movements after receiving midazolam. In one, flumazenil controlled the abnormal movements. Flumazenil is a potent benzodiazepine antagonist that competitively blocks the central effects of benzodiazepines. It can reverse the sedative effects of benzodiazepines occurring after diagnostic or therapeutic procedures or after benzodiazepine overdose. Flumazenil may be considered in cases of abnormal movements associated with midazolam. However, further studies are needed to provide guidelines for the administration of this drug in newborns.<\/jats:p>","DOI":"10.1592\/phco.21.6.642.34545","type":"journal-article","created":{"date-parts":[[2004,6,9]],"date-time":"2004-06-09T06:25:36Z","timestamp":1086762336000},"page":"642-646","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Flumazenil's Reversal of Myoclonic\u2010like Movements Associated with Midazolam in Term Newborns"],"prefix":"10.1002","volume":"21","author":[{"given":"Win","family":"Zaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Knoppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orlando","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01731149"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/000992289703600803"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/0310057X8201000408","article-title":"Midazolam for the intravenous induction of anaesthesia in children","volume":"10","author":"Holloway A.M.","year":"1982","journal-title":"Anaesth Intens Care"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.150.2.377"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.1998.tb11559.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92077-X"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199835010-00003"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01958970"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93235-2"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000457484","article-title":"Comparison of the effect of midazolam or vecuronium on blood pressure and cerebral blood flow velocity in the premature newborn","volume":"19","author":"Straaten H.L.","year":"1992","journal-title":"Dev Pharmacol Ther"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01956430"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.1997.tb01611.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/000992289703601202"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb01844.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/emj.15.4.244"},{"key":"e_1_2_1_17_2","first-page":"361","volume-title":"Goodman and Gilman's the pharmacologic basis of therapeutics","author":"Hobbs W.R.","year":"1996"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1542\/peds.89.6.1129","article-title":"Neurotoxicity of lorazepam in premature infant","volume":"89","author":"Cronin C.M.","year":"1992","journal-title":"Pediatrics"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000244123"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809302700611"},{"key":"e_1_2_1_21_2","first-page":"146","article-title":"Stereotypic movements after lorazepam administration in premature infants: a series and review of the literature","volume":"15","author":"Sexon W.R.","year":"1995","journal-title":"J Perinatol"},{"key":"e_1_2_1_22_2","first-page":"98","article-title":"Clonic movements following lorazepam administration in full\u2010term infants","volume":"152","author":"Chess P.R.","year":"1998","journal-title":"Arch Pediatr Adol Med"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.104.3.579"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198904000-00036"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.186"},{"key":"e_1_2_1_26_2","first-page":"1934","volume-title":"AHFS drug information","author":"Anonymous.","year":"1998"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280059"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199631060-00003"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199902000-00020"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-440X(94)90218-6"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0165-6147(97)90675-1","article-title":"The benzodiazepine binding site of GABA(A) receptors","volume":"18","author":"Sigel E.","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"e_1_2_1_32_2","first-page":"247","volume-title":"Anesthesia","author":"Reves J.G.","year":"1994"},{"key":"e_1_2_1_33_2","first-page":"2110","volume-title":"Fatal and neonatal physiology","author":"Johnston M.V.","year":"1998"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(76)91053-2"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-6619-9_7"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82420-5"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1984.tb02145.x"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92085-0"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70066-0"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1991.tb11687.x"},{"key":"e_1_2_1_41_2","first-page":"332","article-title":"Use of flumazenil to reverse the effects of midazolam in children","volume":"35","author":"Nunez A. Rodriguez","year":"1991","journal-title":"Anales Espanoles de Pediatria"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563659109038604"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01955914"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(98)70148-9"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(05)81219-3"},{"key":"e_1_2_1_46_2","first-page":"65","article-title":"Flumazenil reverses paradoxical reaction with midazolam","volume":"38","author":"Rodrigo C.R.","year":"1991","journal-title":"Anesth Prog"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006565-199506000-00013"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0736-4679(96)00029-7"},{"key":"e_1_2_1_49_2","first-page":"423","volume-title":"Pediatric dosage handbook","author":"Taketomo C.K.","year":"2000"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.21.6.642.34545","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.21.6.642.34545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:01:28Z","timestamp":1761069688000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.21.6.642.34545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1592\/phco.21.6.642.34545"],"URL":"https:\/\/doi.org\/10.1592\/phco.21.6.642.34545","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}